News from mimedx, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 27, 2015, 09:00 ET

MiMedx To Present At The Jefferies 2015 Global Healthcare Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

May 19, 2015, 10:39 ET

MiMedx To Present At The 12th Annual Craig-Hallum Institutional Investor Conference

 MiMedx Group, Inc.  (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected...

May 13, 2015, 14:53 ET

MiMedx Announces Publication On CollaFix™, The Company's Next Technology Platform To Be Commercialized

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

May 08, 2015, 08:00 ET

MiMedx Receives 2015 Innovative Technology Award from Novation

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 29, 2015, 10:20 ET

Comparative Effectiveness Study Exhibiting Superior Outcomes Of MiMedx EpiFix® Receives Award At SAWC Conference

MiMedx Group, Inc. (NASDAQ: MDXG) announced today that one oral abstract and four poster abstracts showing the Company's EpiFix® allografts to...

Apr 27, 2015, 19:46 ET

MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 23, 2015, 09:00 ET

MiMedx To Present At The 40th Annual Deutsche Bank Securities Healthcare Conference

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 13, 2015, 16:30 ET

MiMedx Announces Expansion Of Health Plan Coverage

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 13, 2015, 16:15 ET

MiMedx Reports Record First Quarter 2015 Revenue of $40.8 Million

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 03, 2015, 09:34 ET

MiMedx Group, Inc. Announces Release Date for 2015 First Quarter Results

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 01, 2015, 11:36 ET

MiMedx To Present At The 14th Annual Needham Healthcare Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Mar 23, 2015, 17:45 ET

Government Declines to Intervene in Action Against MiMedx

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Mar 17, 2015, 11:11 ET

MiMedx to Present at 3rd Annual Regen Med Investor Day

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Mar 16, 2015, 15:19 ET

MiMedx To Present At Canaccord's 10th Annual Musculoskeletal Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Feb 26, 2015, 07:30 ET

MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Feb 04, 2015, 08:52 ET

MiMedx Announces Release Date For 2014 Full Year Results

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes...

Feb 03, 2015, 09:00 ET

MiMedx Withdraws Complaint Against Organogenesis Without Prejudice To Focus On Investigation

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jan 12, 2015, 08:45 ET

MiMedx Announces over 30 National Account Contracts

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jan 12, 2015, 08:15 ET

MiMedx Exceeds Fourth Quarter And Full Year 2014 Revenue Forecasts

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jan 06, 2015, 11:35 ET

MiMedx Announces $10 Million Increase to Stock Repurchase Program

 MiMedx Group, Inc.  (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected...